Literature DB >> 2726354

Massive hepatomegaly, steatosis, and secondary plasma carnitine deficiency in an infant with cystic fibrosis.

W R Treem1, C A Stanley.   

Abstract

Hepatomegaly and steatosis are common findings in children with cystic fibrosis and are most often attributed to malnutrition. An infant fed a carnitine-free soy formula is described. Massive hepatomegaly and steatosis developed in the baby at a time of severe viral respiratory illness, prolonged fasting, hypoglycemia, and hypoketonuria. The infant was found to have secondary plasma carnitine deficiency and excessive loss of carnitine in the urine as part of a more generalized renal tubular dysfunction accompanying vitamin D deficiency and secondary hyperparathyroidism. With correction of the metabolic abnormalities and institution of a high carnitine diet, the hepatomegaly disappeared, plasma carnitine returned to normal levels, and the renal carnitine loss ceased. The findings suggest that secondary carnitine deficiency may play a role in fatty infiltration of the liver in patients with cystic fibrosis, especially during times of severe fasting stress.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2726354

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis.

Authors:  Razan M Bader; Maureen M Jonas; Paul D Mitchell; Shanna Wiggins; Christine K Lee
Journal:  J Cyst Fibros       Date:  2018-12-01       Impact factor: 5.482

Review 2.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Thomas Kelly; James Buxbaum
Journal:  Dig Dis Sci       Date:  2015-02-04       Impact factor: 3.199

3.  Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis Patients.

Authors:  Harold Tabori; Anke Jaudszus; Christin Arnold; Hans-Joachim Mentzel; Michael Lorenz; Ruth K Michl; Thomas Lehmann; Diane M Renz; Jochen G Mainz
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

Review 4.  The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  Dragana Savic; Leanne Hodson; Stefan Neubauer; Michael Pavlides
Journal:  Nutrients       Date:  2020-07-22       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.